申请人:Wyeth
公开号:US06667303B1
公开(公告)日:2003-12-23
Aryl substituted 1,4-diazepanes are provided such as derivatives of 6-(1,4-diazepan-1-yl)benzo[cd]indol-2(1H)-one, 6-(1,4-diazepan-1-yl)acenaphthylen-1(2H)-one and 5-(1,4-diazepan-1-yl)-2H-naphtho[1,8-cd]isothiazole-1,1-dioxide. Also provided are pharmaceutical compositions containing one or more of the aryl substituted 1,4-diazepanes. The aryl substituted 1,4-diazepanes are useful for treating disorders or deficiencies associated with the 5-HT2C receptor.
提供了取代芳基的1,4-二氮杂辛烷类化合物,例如6-(1,4-二氮杂辛-1-基)苯并[cd]吲哚-2(1H)-酮、6-(1,4-二氮杂辛-1-基)蒽醌-1(2H)-酮和5-(1,4-二氮杂辛-1-基)-2H-萘[1,8-cd]异噻唑-1,1-二氧化物的衍生物。还提供了含有一种或多种取代芳基的1,4-二氮杂辛的药物组合物。这些取代芳基的1,4-二氮杂辛对治疗与5-HT2C受体相关的疾病或缺陷有用。